CPIX — Cumberland Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $21.00m
- $18.24m
- $39.55m
- 64
- 83
- 46
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.55 | -3.42 | -3.6 | -5.65 | -6.33 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.703 | 0.531 | -2.84 | -1.67 | 2.85 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.43 | 3.53 | 8.18 | 10.4 | 4.63 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 3.06 | 5.42 | 6.34 | 8.45 | 6.09 |
Capital Expenditures | -1.02 | -2.11 | -0.354 | -2.07 | -0.453 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 3.32 | 0.356 | -0.147 | -11.6 | 0.347 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2.3 | -1.76 | -0.502 | -13.7 | -0.106 |
Financing Cash Flow Items | -0.086 | -1.76 | -2.17 | -2.21 | -3.27 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.08 | -7.12 | -3.55 | -2.06 | -7.42 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.274 | -3.46 | 2.29 | -7.28 | -1.44 |